Greetings to You, our Valued Investors and Supporters,

Over the past year, our unwavering commitment to excellence has borne fruit, and we've achieved extraordinary results.

Our share price has soared by an astounding 78%, a testament to the dedication and innovation of our team. We are redefining the boundaries of what's possible in the fields of pharmaceuticals and consumer packaged goods.

2023 has been an incredible year for Rexis Biotech, filled with monumental milestones that are reshaping our industry.

To highlight five key achievements that define our remarkable journey:

1. Unprecedented Revenues: We're currently projecting 2023 revenues of $14.7 million, a testament to our strong growth and market presence.
2. Global Leadership: Rexis is now the largest cannabis beverage manufacturer in the world, with operations spanning three countries.
3. Expanding Horizons: We've secured ownership stakes in several Hemp and THC manufacturing corporations, with a combined annual revenue projection of over $10.5 million over the next 18 months.
4. Pharmaceutical-Grade Innovation: Our pharmaceutical-grade therapeutics are market-ready, poised to make a significant impact in the healthcare landscape.
5. Strategic Collaborations: In less than a year, we've inked multi-year revenue-generating contracts with seven of the country's most respected brands, demonstrating the trust our partners place in us.

This is just the beginning of our journey. Please share Our WeFunder Page to get others on this ride. Your investment means a front-row seat to innovation and global growth.

Thank you for your continued support and belief in Rexis... and our 'Secret Sauce'.

Warm regards,

The Rexis Team